EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Combination Therapeutic Effect of Psoralen and Paclitaxel-Loaded Superparamagnetic Iron Oxide Nanoparticles for the Treatment of Triple-Negative Breast Cancer

Manling Du iD, Fengjie Liu, Panpan Wang, Mulazim Hussain Asim iD, Qian Liu, Qianwen Li, Mengjie Xie, Kewei Zhang, Zhenjiang Yang, Yu Cai iD

International Journal of Nanomedicine · 2026

DOI: 10.2147/ijn.s641922 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2026. Verfasst von Manling Du und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, Guangzhou, People's Republic of China. Hauptthemen laut MEDLINE: Paclitaxel, Triple Negative Breast Neoplasms, Magnetic Iron Oxide Nanoparticles, Ficusin. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To overcome dose-limiting toxicity and paclitaxel (PTX) resistance in triple-negative breast cancer (TNBC) therapy, as well as the asynchronous in vivo biodistribution of PTX and psoralen (PSO) combination regimens, we developed a highly biocompatible, magnetically targeted nano-co-delivery system.

Methods

Paclitaxel/psoralen-loaded magnetic composite nanoparticles (P/P-TCNs) were fabricated via nanoprecipitation. The nanocarriers comprise a poly(lactic-co-glycolic acid) (PLGA) core co-encapsulating both therapeutic agents and superparamagnetic iron oxide nanoparticles (SPIONs), shielded by a stabilizing outer phospholipid layer.

Results

Physiochemically, P/P-TCNs exhibited uniform nanoscale dimensions, a negative surface charge, robust superparamagnetism, and synchronized drug release profiles. In vitro, P/P-TCNs significantly enhanced intracellular drug accumulation in 4T1 murine breast cancer cells, inducing profound G2/M cell cycle arrest and augmented apoptotic response. In vivo live imaging of tumor-bearing mice revealed that under an external magnetic field, P/P-TCNs selectively and efficiently accumulated at the tumor site via tail vein injection. This magnetically guided co-delivery achieved a potent tumor inhibition rate of >85%, significantly outperforming both the free drug combination and non-targeted nanoparticle controls. Furthermore, the nanoplatform demonstrated excellent hemocompatibility (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PaclitaxelTriple Negative Breast NeoplasmsMagnetic Iron Oxide NanoparticlesFicusinAntineoplastic Combined Chemotherapy ProtocolsAnimalsFemaleCell Line, TumorMiceHumansTissue DistributionPolylactic Acid-Polyglycolic Acid CopolymerApoptosisMice, Inbred BALB CPolyglycolic AcidLactic Acid

Stichwörter der Autor:innen

paclitaxelpsoralensuperparamagnetic iron oxide nanoparticlestriple-negative breast cancer

Substanzen

PaclitaxelFicusinPolylactic Acid-Polyglycolic Acid CopolymerPolyglycolic AcidLactic Acid

Autor:innen und Institutionen

  • State Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, Guangzhou, People's Republic of China.
  • International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Ministry of Education (MOE) of China, Jinan University, Guangzhou, People's Republic of China.
  • Guangdong Key Laboratory of Traditional Chinese Medicine Informatization, Jinan University, Guangzhou, People's Republic of China.
  • International Science and Technology Cooperation Base of Guangdong Province, Jinan University, Guangzhou, People's Republic of China.
  • School of Pharmacy, Jinan University, Guangzhou, People's Republic of China.
  • School of Traditional Chinese Medicine, Jinan University, Guangzhou, People's Republic of China.

ORCID-Profile: Manling Du, Mulazim Hussain Asim, Yu Cai

Zitieren

APA

Du, M., Liu, F., Wang, P., Asim, M. H., Liu, Q., Li, Q., Xie, M., Zhang, K., Yang, Z., & Cai, Y. (2026). Combination Therapeutic Effect of Psoralen and Paclitaxel-Loaded Superparamagnetic Iron Oxide Nanoparticles for the Treatment of Triple-Negative Breast Cancer. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s641922

Vancouver

Du M, Liu F, Wang P, Asim MH, Liu Q, Li Q, et al. Combination Therapeutic Effect of Psoralen and Paclitaxel-Loaded Superparamagnetic Iron Oxide Nanoparticles for the Treatment of Triple-Negative Breast Cancer. International Journal of Nanomedicine. 2026. doi:10.2147/ijn.s641922

BibTeX
@article{Du2026,
  author = {Du, Manling and Liu, Fengjie and Wang, Panpan and Asim, Mulazim Hussain and Liu, Qian and Li, Qianwen and Xie, Mengjie and Zhang, Kewei and Yang, Zhenjiang and Cai, Yu},
  title = {Combination Therapeutic Effect of Psoralen and Paclitaxel-Loaded Superparamagnetic Iron Oxide Nanoparticles for the Treatment of Triple-Negative Breast Cancer},
  journal = {International Journal of Nanomedicine},
  year = {2026},
  doi = {10.2147/ijn.s641922}
}
Kostenlos starten →